Stock Movers Intel Falls, Eli Lilly Drops, DoorDash Rises on Rosy Outlook
Aug 7, 2025
Intel's stock takes a hit after political pressure mounts on its CEO, raising concerns about the company's role in the semiconductor industry. Meanwhile, Eli Lilly faces a drop in shares due to disappointing results from a highly anticipated weight loss pill. On a brighter note, DoorDash celebrates a surge in stock value as its third-quarter outlook exceeds expectations, indicating robust demand for its delivery services despite economic uncertainties.
AI Snips
Chapters
Transcript
Episode notes
Intel CEO Under Intense Scrutiny
- Intel faces pressure as President Trump calls for CEO resignation over conflict of interest concerns.
- The company's focus on US semiconductor industry restoration is challenged by these allegations.
Eli Lilly’s Weight Loss Setback
- Eli Lilly’s stock drops sharply due to disappointing weight loss pill study results.
- The new pill showed less weight loss and more nausea than expected, overshadowing other growth.
Personal DoorDash Experience
- Norma shares her personal experience switching to DoorDash due to discounts, reflecting consumer trends.
- DoorDash’s strong outlook raised shares, signaling resilient demand amid economic concerns.